Clinical nutrition ESPEN · 2026
Preoperative Muscle Quality and Postoperative Computed Tomography-Defined Muscle Loss Predict Prognosis After Gastrectomy for Gastric Cancer.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Urakawa Shinya, Hirao Takafumi, Moriwaki Fuko, Oyama Keisuke, Higashiguchi Masaya, Nomura Masatoshi, Abe Kaori, Fukata Tadafumi, Noguchi Kozo, Danno Katsuki, Nakane Shigeru, Konishi Eriko, Miyoshi Yasuo, Sekimoto Mitsugu, Oka Yoshio
Аннотация
BACKGROUND & AIMS: Body weight (BW) loss after gastrectomy is commonly monitored, but it may not accurately reflect skeletal muscle depletion. We investigated the prognostic significance of postoperative CT-defined muscle loss after curative gastrectomy, with RFS as the primary endpoint.
METHODS: We retrospectively analyzed 341 patients with pStage I-III gastric cancer who underwent curative gastrectomy and had evaluable CT at approximately 6 months after surgery. Preoperative intramuscular adipose tissue content (IMAC) and postoperative psoas muscle index (PMI) loss were evaluated in relation to recurrence-free survival (RFS) and overall survival (OS).
RESULTS: The correlation between 6-month BW loss and PMI loss was weak (R2=0.063, p<0.001), with discordant phenotypes in 39.8% of patients. On multivariable analysis, in addition to pT4 and pN positivity, both high preoperative IMAC and high PMI loss rate remained independently associated with worse RFS (Hazard Ratio (HR) 1.90 and 6.41, respectively) and OS (HR 1.68 and 2.95, respectively), whereas preoperative PMI and BW loss rate were not significant. Combined stratification further identified patients with both high preoperative IMAC and high postoperative PMI loss as having the poorest prognosis; their 5-year RFS and OS rates were 51.0% and 41.9%, respectively, compared with 93.2% and 84.3% in the Low/Low group.
CONCLUSIONS: BW loss is an imprecise surrogate for postoperative muscle depletion. Preoperative muscle quality and postoperative muscle loss provide complementary prognostic information after gastrectomy.
METHODS: We retrospectively analyzed 341 patients with pStage I-III gastric cancer who underwent curative gastrectomy and had evaluable CT at approximately 6 months after surgery. Preoperative intramuscular adipose tissue content (IMAC) and postoperative psoas muscle index (PMI) loss were evaluated in relation to recurrence-free survival (RFS) and overall survival (OS).
RESULTS: The correlation between 6-month BW loss and PMI loss was weak (R2=0.063, p<0.001), with discordant phenotypes in 39.8% of patients. On multivariable analysis, in addition to pT4 and pN positivity, both high preoperative IMAC and high PMI loss rate remained independently associated with worse RFS (Hazard Ratio (HR) 1.90 and 6.41, respectively) and OS (HR 1.68 and 2.95, respectively), whereas preoperative PMI and BW loss rate were not significant. Combined stratification further identified patients with both high preoperative IMAC and high postoperative PMI loss as having the poorest prognosis; their 5-year RFS and OS rates were 51.0% and 41.9%, respectively, compared with 93.2% and 84.3% in the Low/Low group.
CONCLUSIONS: BW loss is an imprecise surrogate for postoperative muscle depletion. Preoperative muscle quality and postoperative muscle loss provide complementary prognostic information after gastrectomy.